Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Mol Cell. 2017 May 18;66(5):711–720.e3. doi: 10.1016/j.molcel.2017.05.004
Crystallization conditions for human CTCF-DNA complexes
ZF2-7 + DNA 15% (w/v) PEG 4K, 0.2 M ammonium acetate, 0.1 M Na Citrate pH 5.6
ZF3-7 + DNA 25% (w/v) PEG 3350, 0.2 M ammonium acetate, 0.1 M Tris pH 8.5
ZF3-7 + methylated DNA 25% (w/v) PEG 3350, 0.2 M NaCl, 0.1 M Hepes pH 7.5
ZF4-7 + DNA 25% (w/v) PEG 3350, 0.2 M ammonium acetate, 0.1 M Bis-Tris HCl, pH 5.5
ZF5-8 +DNA (P65) 20% (w/v) PEG 3350, 0.2 M ammonium sulfate, 0.1 M sodium cacodylate pH 6.5
ZF5-8 +DNA (P41212) 25% (w/v) PEG 3350, 0.2 M ammonium acetate, 0.1 M Bis-Tris HCl, pH 5.5
ZF6-8 + DNA 20% (w/v) PEG 8000, 0.1 M CHES-NaOH pH 9.5
ZF4-10 + DNA 28% (w/v) PEG 2K MME, 0.1 M Bis-Tris HCl pH 6.5
ZF4-11 + DNA 28% (w/v) PEG 2K MME, 0.1 M Bis-Tris HCl pH 6.5